Highly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specific chemotherapy
Kenji Kono1, Toshiaki Ozawa, Tomohide Yoshida
1Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, 1-1 Gakuen-cho, Sakai, Osaka, Japan. kono@chem.osakafu-u.ac.jp
Biomaterials
|June 29, 2010
Summary
Temperature-sensitive liposomes loaded with doxorubicin (DOX) were developed using a novel polymer. Localized hyperthermia significantly enhanced tumor suppression, demonstrating potential for targeted cancer chemotherapy.
Area of Science:
- Biomedical Engineering
- Materials Science
- Oncology
Background:
- Polymer incorporation can create temperature-sensitive liposomes.
- Poly[2-(2-ethoxy)ethoxyethyl vinyl ether] (EOEOVE) exhibits a lower critical solution temperature around 40°C.
- Thermosensitive liposomes offer potential for targeted drug delivery.
Purpose of the Study:
- To prepare temperature-sensitive liposomes for tumor-specific chemotherapy using doxorubicin (DOX).
- To evaluate the drug release, circulation, and biodistribution properties of these liposomes.
- To assess the efficacy of DOX-loaded liposomes combined with localized hyperthermia in a tumor model.
Main Methods:
- Liposomes were prepared using PEG-lipid, egg yolk phosphatidylcholine, cholesterol, and a synthesized EOEOVE-block-octadecyl vinyl ether copolymer.
- Doxorubicin (DOX) encapsulation and release kinetics at different temperatures were measured.
- Liposome circulation and biodistribution were assessed in vivo.
- Tumor growth suppression was evaluated in tumor-bearing mice treated with DOX-loaded liposomes and localized hyperthermia.
Main Results:
- Copolymer-incorporated liposomes showed stability below physiological temperatures and rapid DOX release above 40°C (complete release within 1 min at 45°C).
- The modified liposomes exhibited long circulation times and biodistribution similar to PEG-ylated liposomes.
- Intravenous injection of DOX-loaded liposomes combined with localized tumor heating (45°C for 10 min) strongly suppressed tumor growth in mice.
- Without localized heating, the liposomes showed only slight tumor-suppressive effects.
Conclusions:
- The developed copolymer-modified liposomes demonstrate significant temperature-sensitive drug release properties.
- Combining these liposomes with localized hyperthermia enables effective and tumor-selective chemotherapy.
- This approach holds promise for improving the efficacy of cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...